Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 10 August 2010
Vol. 3, Issue 134, p. ec245
[DOI: 10.1126/scisignal.3134ec245]


Atherosclerosis Limiting Lesions

Elizabeth M. Adler

Science Signaling, AAAS, Washington, DC 20005, USA

B cells, unlike other elements of the immune response, have been thought to protect against development of atherosclerosis, a matter of concern in light of the use of targeted therapies aimed at decreasing the number of mature B cells in various immune-related disorders. Interested in exploring the role of B cells in atherosclerosis, Ait-Oufella et al. evaluated the effects of treatment with a monoclonal antibody directed against CD20 (CD20 mAb, used to deplete mature B cells) on development of atherosclerotic lesions in a mouse model [mice lacking apolipoprotein E (Apoe–/– mice) fed a high-fat diet]. Unexpectedly, they found that, although CD20 mAB failed to affect plasma cholesterol, it decreased lesion size. Similar effects of B cell depletion were apparent in another mouse model of atherosclerosis, mice lacking the low-density lipoprotein receptor. Further analysis of atherosclerotic lesions revealed a decrease in macrophage accumulation in the lesions of CD20 mAb-treated mice, as well as a decrease in the abundance of T cells and B cells. Spleen-derived CD4+ T cells from mice treated with CD20 mAb showed decreased activation and proliferation compared with those from untreated mice. Moreover, dendritic cells from CD20 mAb-treated mice showed decreased abundance of CD40 and were less effective than control dendritic cells at stimulating the in vitro proliferation of T cells from untreated mice. Cytokines derived from T cells affect the development of atherosclerotic lesions, and analyses of the cytokine profiles of purified T cells revealed changes consistent with the antiatherosclerotic effects of B cell depletion [decreased interferon-{gamma} and increased interleukin 17 (IL-17) in T cells from B cell–depleted compared with control mice]. Indeed, administration of a neutralizing antibody directed against IL-17 concurrently with CD20 mAb blocked the atheroprotective effects of the latter. The authors thus conclude that B cell depletion is protective against atherosclerosis and that B cell manipulation might provide an antiatherogenic strategy.

H. Ait-Oufella, O. Herbin, J.-D. Bouaziz, C. J. Binder, C. Uyttenhove, L. Laurans, S. Taleb, E. Van Vré, B. Esposito, J. Vilar, J. Sirvent, J. Van Snick, A. Tedgui, T. F. Tedder, Z. Mallat, B cell depletion reduces the development of atherosclerosis in mice. J. Exp. Med. 207, 1579–1587 (2010). [Abstract] [Full Text]

Citation: E. M. Adler, Limiting Lesions. Sci. Signal. 3, ec245 (2010).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882